NL-OMON47886
Completed
Not Applicable
Assessing the frequency, phenotype and function of plasmacytoid dendritic cells and T cells in blood and skin of patients with skin fibrosing disorders - Analysis of immune cells in skin fibrosing disorders
niversitair Medisch Centrum Utrecht0 sites150 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Systemic sclerosis - scleroderma / Localized scleroderma - morphea / Eosinophilic fasciitis - ?
- Sponsor
- niversitair Medisch Centrum Utrecht
- Enrollment
- 150
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\-Age range: 18 \- 75 years
- •\-Diagnosed with systemic sclerosis, localized scleroderma, eosinophilic fasciitis or psoriasis.
Exclusion Criteria
- •\-\-Current use of coumarin derivatives
- •\-Current use of cyclophosphamide
- •\-IV corticosteroids in the last 14 days for inclusion
- •\-Age \<\=17 years
- •\-Patients with contra\-indications for undergoing a skin biopsy (for example allergic to topical anesthetics)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
An investigation into the prevalence of MSC and the effectiveness of an intervention program for these patientsPACTR201511000689333Research Directorate, University of the Free State74
Not yet recruiting
Not Applicable
Identification and functional characterization of causal genetic variants in patients with an unexplained bleeding tendencyplaatjesaandoeningenRare bleeding disorders1006447710005330NL-OMON53364Radboud Universitair Medisch Centrum30
Recruiting
Not Applicable
Functional and structural characterization of the myocardiumdiseases connected to heart failure (e.g. cardiomyopathy)I42CardiomyopathyDRKS00011097niversitätsklinikum Würzburg, Deutsches Zentrum für Herzinsuffizienz50
Not yet recruiting
Not Applicable
Role of bacteria secreted vesicles in diabetic foot ulcerHealth Condition 1: E119- Type 2 diabetes mellitus without complicationsCTRI/2023/09/057818Science and Engineering research Board (SERB) - Core Research Grant
Active, not recruiting
Phase 1
Definition of the clinicla manifestation variability, response to treatment and natural history in Pearson and Kearns-Sayre syndromePearson and Kearns-Sayre syndrome.MedDRA version: 20.1Level: PTClassification code 10058799Term: Mitochondrial encephalomyopathySystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 20.1Level: PTClassification code 10051403Term: Mitochondrial DNA deletionSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 20.0Level: LLTClassification code 10074070Term: Mitochondrial encephalopathySystem Organ Class: 10010331 - Congenital, familial and genetic disordersTherapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2019-003028-19-ITIRCCS, OSPEDALE PEDIATRICO BAMBINO GESÙ DI ROMA27